<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02056288</url>
  </required_header>
  <id_info>
    <org_study_id>H-27386</org_study_id>
    <nct_id>NCT02056288</nct_id>
  </id_info>
  <brief_title>A Comparison of UGSB and GA to IV Narcotics and GA for Post-Op Pain in Children With Supracondylar Fractures.</brief_title>
  <official_title>A Randomized Comparison of Ultrasound Guided Supraclavicular Block(UGSB) and General Anesthesia (GA) to IV Narcotics and General Anesthesia for Postoperative Pain Relief in Children With Supracondylar Fractures.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baylor College of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baylor College of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares nerve blocks to IV pain medicines in children with broken arms. We are&#xD;
      trying to see if blocking the nerves in the broken arm results in better pain control and&#xD;
      less side effects than injections of morphine into a vein after surgery for a broken elbow.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Written consent will be obtained by the investigators prior to the surgical procedure using&#xD;
      the Institutional Review Board (IRB) approved consent form. The medical record will be&#xD;
      examined and the use of any analgesic medications in the 24 hours prior to the procedure will&#xD;
      be recorded. Patients will be taken to the OR and anesthetized using standard procedures of&#xD;
      the Texas Children's Hospital (TCH) department of anesthesia, including monitoring according&#xD;
      to the American Society of Anesthesiologists guidelines (EKG, pulse oximetry, BP, temperature&#xD;
      and end-tidal expired carbon dioxide and inhalation anesthetic gases). If the Attending&#xD;
      Anesthesiologist believes the child is at risk for aspiration of gastric contents, a rapid&#xD;
      sequence induction with propofol 3-4 mg/kg and succinylcholine 1mg/kg IV will be performed&#xD;
      with cricoid pressure, in keeping with standard practices. In other patients an IV will be&#xD;
      started after induction of anesthesia. An age appropriate endotracheal tube or appropriate&#xD;
      sized laryngeal mask airway (LMA) will be inserted in all patients. Anesthesia will be&#xD;
      maintained with sevoflurane, nitrous oxide and oxygen, adjusted to keep blood pressure and&#xD;
      heart rate within 20% of baseline values, in keeping with standard practices. All patients&#xD;
      will receive ketorolac 0.5mg/kg IV.&#xD;
&#xD;
      Patients will be randomized in a 1:1 ratio into one of two study groups: ultrasound guided&#xD;
      supraclavicular block or IV opioids, based on a computer generated random number by using&#xD;
      Random Allocation Software For Parallel Group Randomized Trials. The assignment will be made&#xD;
      only after written informed consent has been obtained. There will be an equal chance a child&#xD;
      will be assigned to one of the two groups. Patients randomized to the systemic analgesia&#xD;
      group will receive 1mcg/kg of fentanyl IV after induction. Patients randomized to the&#xD;
      supraclavicular block group will receive an ultrasound guided nerve block with 0.2 ml/kg&#xD;
      ropivacaine 0.5% (maximum 10 ml), using the technique described by Marhofer et al. In order&#xD;
      to decrease variance in success rates, the ultrasound guided nerve block will be performed by&#xD;
      1 of the 4 anesthesiology co-investigators, each of whom have successfully performed over 100&#xD;
      ultrasound guided blocks in the past. Supraclavicular blocks were performed using the higher&#xD;
      frequency of the probe and placing it in a coronal-oblique-plane in the supraclavicular&#xD;
      fossa. The brachial plexus will be identified as a cluster of hypoechoic nodules, lateral to&#xD;
      the round pulsating hypoechoic subclavian artery and lying on top of the hyperechoic first&#xD;
      rib. The cupola of the lung will be identified. If the transverse colli artery is visualized&#xD;
      cephalically surrounding the plexus, the probe will be moved toward a better coronal oblique&#xD;
      plane, directing the ultrasound beam slightly caudally, in order to keep the artery away from&#xD;
      the plexus. The needle will be was carefully introduced using an in-plane (IP) technique from&#xD;
      lateral to medial, toward but not into the brachial plexus. The entire needle image will be&#xD;
      visualised at all times to ensure it does not enter the vessel, nerve plexus or pleura. The&#xD;
      spread of local anesthetic to all targets of the plexus will be observed on the ultrasound&#xD;
      image.&#xD;
&#xD;
      The time taken to place the block will be recorded from the time the ultrasound probe is&#xD;
      first placed on the child until completion of local anesthetic injection. The observer&#xD;
      collecting postoperative data will not be present when the block is placed, and a band-aid&#xD;
      will be placed over the supraclavicular fossa in all patients to maintain blinding of the&#xD;
      observer to the group assignment. During the operation patients can receive intraoperative&#xD;
      fentanyl, 1 mcg/kg IV at a time, if the attending anesthesiologist believes it is clinically&#xD;
      indicated. At the end of the operation, anesthetic gases will be discontinued while the&#xD;
      patient breathes 100% oxygen. The trachea will be extubated when the patient responds to&#xD;
      commands, and the child will then be taken to the Post Anesthetic Care Unit (PACU) in keeping&#xD;
      with standard practices . A validated pain scale (verbal rating scale where 0 = no pain and&#xD;
      10 = worst possible pain ever) will be used throughout to assess the severity of pain in the&#xD;
      postoperative period. In keeping with current practice, patients with pain scores&gt;4 will be&#xD;
      treated with morphine 0.05mg/kg IV at 10 minute intervals until the score is below 4. Oral&#xD;
      acetaminophen with hydrocodone (Lortab elixir 0.15mg/kg hydrocodone) will be administered to&#xD;
      children for pain scores between 2- 3. Supplemental oxygen, rescue antiemetic and&#xD;
      antipruritic drugs will be administered in keeping with standard practices of TCH and the&#xD;
      clinical judgment of the Attending Anesthesiologist. The duration of supplemental oxygen&#xD;
      therapy, any medication administered and complications (side effects such as nausea,&#xD;
      vomiting, itching, respiratory depression, prolonged awakening) will be recorded on the case&#xD;
      report form.&#xD;
&#xD;
      The blinded observer will record pain scores within 15 minutes of arrival in the PACU and at&#xD;
      30 minutes, 1,2,6,12,24, and 48 hours after arrival in the PACU. If the child is sleeping at&#xD;
      this time, the scores will be recorded when awake. Prior to discharge home, parents will be&#xD;
      educated on use of the 0-10 pain scale and given a diary to keep an accurate record of&#xD;
      postoperative pain issues through the study period. The goal is to capture maximum pain&#xD;
      scores at rest and with movement. Patient and parental satisfaction with pain management and&#xD;
      with the global perioperative experience will also be graded on a numeric scale 0-10 scale.&#xD;
&#xD;
      Time to readiness for discharge will also be measured from the time the patient enters the&#xD;
      PACU to when the patient attains an Aldrete score of 9-10. This is a standardized scale used&#xD;
      to assess discharge readiness at TCH and is listed below:&#xD;
&#xD;
      Aldrete Scoring System Activity Can move voluntarily or on command 4 extremities 2 2&#xD;
      extremities 1 0 extremities 0 Respiration Can deep-breathe and cough freely 2 Dyspnea,&#xD;
      shallow or limited breathing 1 Apneic 0 Circulation Preoperative BP (mmHg) BP ± 20 mmHg of&#xD;
      baseline 2 BP ± 20-50 mmHg of baseline 1 BP ± 20 mmHg 0 Consciousness Fully Awake 2 Arousable&#xD;
      on calling 1 Not responding 0 Color Normal 2 Pale, dusky, blotchy 1 Cyanotic 0 Score of 10:&#xD;
      ready for discharge&#xD;
&#xD;
      If the patient is discharged before the end of a 48 hour period after surgery, they will be&#xD;
      given a diary to complete to list all medications given, and to assess their pain at various&#xD;
      time intervals (12,24, 48 hours after surgery), along with their satisfaction with pain&#xD;
      control. The patient will be contacted after discharge to obtain the data in the diary. Phone&#xD;
      calls will also be placed on Post- operative Day (POD) #1,2, &amp; 3 to the family following to&#xD;
      assess measured endpoints (pain, medication usage, satisfaction, resolution of nerve block).&#xD;
&#xD;
      At the time of their follow up visit to the surgeon, a complete physical examination will be&#xD;
      done including a neurological evaluation for any nerve injury.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Enrollment was suspended due to the duration of the study and poor follow-up response by&#xD;
    participants.&#xD;
  </why_stopped>
  <start_date type="Actual">March 10, 2011</start_date>
  <completion_date type="Actual">March 1, 2019</completion_date>
  <primary_completion_date type="Actual">February 11, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Opioid Consumption</measure>
    <time_frame>up to 48 hours after surgery</time_frame>
    <description>Opioid administration measured in mg/kg. Results below represent the total opioids given in the PACU, after discharge from the PACU, and then total post-operative period.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time of First Analgesia Request</measure>
    <time_frame>PACU Period up to 3 hours</time_frame>
    <description>Time at which additional analgesia was requested and/or administered by the nurse while in the PACU. Discharge data not reported due to poor diary return compliance.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time of Achieving Discharge Readiness</measure>
    <time_frame>From the time of PACU arrival up to time the patient achieves an Aldrete Score of 9- 10.</time_frame>
    <description>Documented time that patient achieves an Aldrete Score of 9 -10. This is a standardized scale used to assess discharge readiness at Texas Children's Hospital.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Side Effects</measure>
    <time_frame>up to 48 hours after surgery</time_frame>
    <description>Documented side effects such as nausea, vomiting, pruritus, and respiratory depression.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient and Parent Satisfaction</measure>
    <time_frame>up to 48 hours after surgery</time_frame>
    <description>Child subject and parent satisfaction with pain management was measured using the global perioperative experience graded on a numeric scale of 0 - 10, with 0 indicating poor management to 10 indicating excellent pain management. Satisfaction is reported at 12-, 24-, 48-hours, and overall at home.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Mean Pain Score in the Postoperative Period</measure>
    <time_frame>From admission to PACU to 48 hours after surgery</time_frame>
    <description>The Verbal Numeric Scale (VNS) asks patients to verbally state a number between 0 and 10 that corresponds to their present pain intensity. 0 = no pain and 10 = worst possible pain ever. Pain was measured by the child subject in the PACU at arrival, 15-, 30-, 60- and 120-minutes. Pain was assessed by the child subject and a parent at home at 12-, 24-, and 48-hours after surgery. The results represent a mean of all verbal pain scores in the PACU, while at home, and overall.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">78</enrollment>
  <condition>Supracondylar Fractures</condition>
  <arm_group>
    <arm_group_label>Ultrasound Guided Supraclavicular block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients randomized to the supraclavicular block group will receive an ultrasound guided nerve block with 0.2 ml/kg ropivacaine 0.5% (maximum 10 ml), using the technique described by Marhofer et al. In order to decrease variance in success rates, the ultrasound guided nerve block will be performed by 1 of the 4 anesthesiology co-investigators, each of whom have successfully performed over 100 ultrasound guided blocks in the past. Supraclavicular blocks were performed using the higher frequency of the probe and placing it in a coronal-oblique-plane in the supraclavicular fossa.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IV Opioids</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction.</description>
    <arm_group_label>IV Opioids</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction. Patients randomized to the supraclavicular block group will receive an ultrasound guided nerve block with 0.2 ml/kg ropivacaine 0.5% (maximum 10 ml).</description>
    <arm_group_label>Ultrasound Guided Supraclavicular block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        1) Supracondylar fracture (2) Age 2-17 years (3) American Society of Anesthesiologists&#xD;
        Status 1 -3 (4) Scheduled for closed reduction with percutaneous pinning under general&#xD;
        anesthesia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Pulseless extremity&#xD;
&#xD;
          2. Compromised neurologic status on exam (specifically assessment of radial, ulnar, and&#xD;
             median nerve)&#xD;
&#xD;
          3. Known allergy to local anesthetics (7) Not scheduled for closed reduction with&#xD;
             percutaneous pinning under general anesthesia&#xD;
&#xD;
          4. Bleeding diathesis&#xD;
&#xD;
          5. American Society of Anesthesiologist (ASA) status 4 or higher.&#xD;
&#xD;
          6. Sleep apnea by polysomnography&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chris Glover, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baylor College of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Melissa Challman, MPH</last_name>
    <role>Study Director</role>
    <affiliation>Baylor College of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Texas Children't Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>February 4, 2014</study_first_submitted>
  <study_first_submitted_qc>February 4, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 5, 2014</study_first_posted>
  <results_first_submitted>January 11, 2021</results_first_submitted>
  <results_first_submitted_qc>May 18, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">May 21, 2021</results_first_posted>
  <last_update_submitted>May 18, 2021</last_update_submitted>
  <last_update_submitted_qc>May 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Baylor College of Medicine</investigator_affiliation>
    <investigator_full_name>Chris Glover</investigator_full_name>
    <investigator_title>Medical Director of Perioperative Services</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 19, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/88/NCT02056288/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Ultrasound Guided Supraclavicular Block</title>
          <description>Patients randomized to the supraclavicular block group will receive an ultrasound guided nerve block with 0.2 ml/kg ropivacaine 0.5% (maximum 10 ml), using the technique described by Marhofer et al. In order to decrease variance in success rates, the ultrasound guided nerve block will be performed by 1 of the 4 anesthesiology co-investigators, each of whom have successfully performed over 100 ultrasound guided blocks in the past. Supraclavicular blocks were performed using the higher frequency of the probe and placing it in a coronal-oblique-plane in the supraclavicular fossa.&#xD;
Ropivacaine: Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction. Patients randomized to the supraclavicular block group will receive an ultrasound guided nerve block with 0.2 ml/kg ropivacaine 0.5% (maximum 10 ml).</description>
        </group>
        <group group_id="P2">
          <title>IV Opioids</title>
          <description>Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction.&#xD;
Fentanyl: Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>In-Hospital Data</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="35"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Surgery cancelled</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>48-Hour Post-Discharge Data</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="35"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Did not return diary</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Ultrasound Guided Supraclavicular Block</title>
          <description>Patients randomized to the supraclavicular block group will receive an ultrasound guided nerve block with 0.2 ml/kg ropivacaine 0.5% (maximum 10 ml), using the technique described by Marhofer et al. In order to decrease variance in success rates, the ultrasound guided nerve block will be performed by 1 of the 4 anesthesiology co-investigators, each of whom have successfully performed over 100 ultrasound guided blocks in the past. Supraclavicular blocks were performed using the higher frequency of the probe and placing it in a coronal-oblique-plane in the supraclavicular fossa.&#xD;
Ropivacaine: Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction. Patients randomized to the supraclavicular block group will receive an ultrasound guided nerve block with 0.2 ml/kg ropivacaine 0.5% (maximum 10 ml).</description>
        </group>
        <group group_id="B2">
          <title>IV Opioids</title>
          <description>Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction.&#xD;
Fentanyl: Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="35"/>
            <count group_id="B2" value="38"/>
            <count group_id="B3" value="73"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="35"/>
                    <count group_id="B2" value="38"/>
                    <count group_id="B3" value="73"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.52" lower_limit="4.21" upper_limit="11.39"/>
                    <measurement group_id="B2" value="6.01" lower_limit="3.84" upper_limit="10.2"/>
                    <measurement group_id="B3" value="6.09" lower_limit="3.84" upper_limit="11.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="35"/>
                    <count group_id="B2" value="38"/>
                    <count group_id="B3" value="73"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="35"/>
                    <count group_id="B2" value="38"/>
                    <count group_id="B3" value="73"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>ASA Physical Status</title>
          <description>The ASA Physical Status Classification System assesses and communicates a patient's pre-anesthesia medical co-morbidities. The ASA System ranges from I to VI with lower scores indicating healthy patients with no systemic disease. ASA I is a normal healthy patient and an ASA VI is a declared brain-dead patient whose organs are being removed for donor purposes.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="35"/>
                    <count group_id="B2" value="38"/>
                    <count group_id="B3" value="73"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>ASA I</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="52"/>
                  </measurement_list>
                </category>
                <category>
                  <title>ASA II</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="35"/>
                    <count group_id="B2" value="38"/>
                    <count group_id="B3" value="73"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24.89" spread="8.07"/>
                    <measurement group_id="B2" value="23.75" spread="5.43"/>
                    <measurement group_id="B3" value="24.29" spread="6.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Opioid Consumption</title>
        <description>Opioid administration measured in mg/kg. Results below represent the total opioids given in the PACU, after discharge from the PACU, and then total post-operative period.</description>
        <time_frame>up to 48 hours after surgery</time_frame>
        <population>Total PACU consumption was able to be calculated for all subjects. Not every subject returned their 48-hour diary. As such, the discharge consumption does not reflect all possible subjects.</population>
        <group_list>
          <group group_id="O1">
            <title>Ultrasound Guided Supraclavicular Block</title>
            <description>Patients randomized to the supraclavicular block group will receive an ultrasound guided nerve block with 0.2 ml/kg ropivacaine 0.5% (maximum 10 ml), using the technique described by Marhofer et al. In order to decrease variance in success rates, the ultrasound guided nerve block will be performed by 1 of the 4 anesthesiology co-investigators, each of whom have successfully performed over 100 ultrasound guided blocks in the past. Supraclavicular blocks were performed using the higher frequency of the probe and placing it in a coronal-oblique-plane in the supraclavicular fossa.&#xD;
Ropivacaine: Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction. Patients randomized to the supraclavicular block group will receive an ultrasound guided nerve block with 0.2 ml/kg ropivacaine 0.5% (maximum 10 ml).</description>
          </group>
          <group group_id="O2">
            <title>IV Opioids</title>
            <description>Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction.&#xD;
Fentanyl: Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction.</description>
          </group>
        </group_list>
        <measure>
          <title>Opioid Consumption</title>
          <description>Opioid administration measured in mg/kg. Results below represent the total opioids given in the PACU, after discharge from the PACU, and then total post-operative period.</description>
          <population>Total PACU consumption was able to be calculated for all subjects. Not every subject returned their 48-hour diary. As such, the discharge consumption does not reflect all possible subjects.</population>
          <units>mg/kg</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Total Intraoperative Opioids</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="35"/>
                    <count group_id="O2" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0.09"/>
                    <measurement group_id="O2" value="0.2" lower_limit="0.11" upper_limit="0.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PACU - 1st 2 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="35"/>
                    <count group_id="O2" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0.05"/>
                    <measurement group_id="O2" value="0.12" lower_limit="0.06" upper_limit="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Home - Hour 2 to 48</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.25" lower_limit="0" upper_limit="0.53"/>
                    <measurement group_id="O2" value="0.04" lower_limit="0" upper_limit="0.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total Opioid Consumption - PACU and Home</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="35"/>
                    <count group_id="O2" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.31" lower_limit="0.05" upper_limit="0.53"/>
                    <measurement group_id="O2" value="0.26" lower_limit="0.10" upper_limit="0.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time of First Analgesia Request</title>
        <description>Time at which additional analgesia was requested and/or administered by the nurse while in the PACU. Discharge data not reported due to poor diary return compliance.</description>
        <time_frame>PACU Period up to 3 hours</time_frame>
        <population>Reflects only subjects who requested analgesia in the PACU.</population>
        <group_list>
          <group group_id="O1">
            <title>Ultrasound Guided Supraclavicular Block</title>
            <description>Patients randomized to the supraclavicular block group will receive an ultrasound guided nerve block with 0.2 ml/kg ropivacaine 0.5% (maximum 10 ml), using the technique described by Marhofer et al. In order to decrease variance in success rates, the ultrasound guided nerve block will be performed by 1 of the 4 anesthesiology co-investigators, each of whom have successfully performed over 100 ultrasound guided blocks in the past. Supraclavicular blocks were performed using the higher frequency of the probe and placing it in a coronal-oblique-plane in the supraclavicular fossa.&#xD;
Ropivacaine: Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction. Patients randomized to the supraclavicular block group will receive an ultrasound guided nerve block with 0.2 ml/kg ropivacaine 0.5% (maximum 10 ml).</description>
          </group>
          <group group_id="O2">
            <title>IV Opioids</title>
            <description>Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction.&#xD;
Fentanyl: Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction.</description>
          </group>
        </group_list>
        <measure>
          <title>Time of First Analgesia Request</title>
          <description>Time at which additional analgesia was requested and/or administered by the nurse while in the PACU. Discharge data not reported due to poor diary return compliance.</description>
          <population>Reflects only subjects who requested analgesia in the PACU.</population>
          <units>Minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76" lower_limit="53" upper_limit="93"/>
                    <measurement group_id="O2" value="27" lower_limit="13" upper_limit="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time of Achieving Discharge Readiness</title>
        <description>Documented time that patient achieves an Aldrete Score of 9 -10. This is a standardized scale used to assess discharge readiness at Texas Children's Hospital.</description>
        <time_frame>From the time of PACU arrival up to time the patient achieves an Aldrete Score of 9- 10.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ultrasound Guided Supraclavicular Block</title>
            <description>Patients randomized to the supraclavicular block group will receive an ultrasound guided nerve block with 0.2 ml/kg ropivacaine 0.5% (maximum 10 ml), using the technique described by Marhofer et al. In order to decrease variance in success rates, the ultrasound guided nerve block will be performed by 1 of the 4 anesthesiology co-investigators, each of whom have successfully performed over 100 ultrasound guided blocks in the past. Supraclavicular blocks were performed using the higher frequency of the probe and placing it in a coronal-oblique-plane in the supraclavicular fossa.&#xD;
Ropivacaine: Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction. Patients randomized to the supraclavicular block group will receive an ultrasound guided nerve block with 0.2 ml/kg ropivacaine 0.5% (maximum 10 ml).</description>
          </group>
          <group group_id="O2">
            <title>IV Opioids</title>
            <description>Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction.&#xD;
Fentanyl: Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction.</description>
          </group>
        </group_list>
        <measure>
          <title>Time of Achieving Discharge Readiness</title>
          <description>Documented time that patient achieves an Aldrete Score of 9 -10. This is a standardized scale used to assess discharge readiness at Texas Children's Hospital.</description>
          <units>Minutes</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72" lower_limit="30" upper_limit="125"/>
                    <measurement group_id="O2" value="94" lower_limit="48" upper_limit="187"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incidence of Side Effects</title>
        <description>Documented side effects such as nausea, vomiting, pruritus, and respiratory depression.</description>
        <time_frame>up to 48 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ultrasound Guided Supraclavicular Block</title>
            <description>Patients randomized to the supraclavicular block group will receive an ultrasound guided nerve block with 0.2 ml/kg ropivacaine 0.5% (maximum 10 ml), using the technique described by Marhofer et al. In order to decrease variance in success rates, the ultrasound guided nerve block will be performed by 1 of the 4 anesthesiology co-investigators, each of whom have successfully performed over 100 ultrasound guided blocks in the past. Supraclavicular blocks were performed using the higher frequency of the probe and placing it in a coronal-oblique-plane in the supraclavicular fossa.&#xD;
Ropivacaine: Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction. Patients randomized to the supraclavicular block group will receive an ultrasound guided nerve block with 0.2 ml/kg ropivacaine 0.5% (maximum 10 ml).</description>
          </group>
          <group group_id="O2">
            <title>IV Opioids</title>
            <description>Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction.&#xD;
Fentanyl: Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Side Effects</title>
          <description>Documented side effects such as nausea, vomiting, pruritus, and respiratory depression.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Nausea</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pruritus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Respiratory Depression</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient and Parent Satisfaction</title>
        <description>Child subject and parent satisfaction with pain management was measured using the global perioperative experience graded on a numeric scale of 0 - 10, with 0 indicating poor management to 10 indicating excellent pain management. Satisfaction is reported at 12-, 24-, 48-hours, and overall at home.</description>
        <time_frame>up to 48 hours after surgery</time_frame>
        <population>Not all subjects returned their 48-hour diary.</population>
        <group_list>
          <group group_id="O1">
            <title>Ultrasound Guided Supraclavicular Block</title>
            <description>Patients randomized to the supraclavicular block group will receive an ultrasound guided nerve block with 0.2 ml/kg ropivacaine 0.5% (maximum 10 ml), using the technique described by Marhofer et al. In order to decrease variance in success rates, the ultrasound guided nerve block will be performed by 1 of the 4 anesthesiology co-investigators, each of whom have successfully performed over 100 ultrasound guided blocks in the past. Supraclavicular blocks were performed using the higher frequency of the probe and placing it in a coronal-oblique-plane in the supraclavicular fossa.&#xD;
Ropivacaine: Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction. Patients randomized to the supraclavicular block group will receive an ultrasound guided nerve block with 0.2 ml/kg ropivacaine 0.5% (maximum 10 ml).</description>
          </group>
          <group group_id="O2">
            <title>IV Opioids</title>
            <description>Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction.&#xD;
Fentanyl: Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient and Parent Satisfaction</title>
          <description>Child subject and parent satisfaction with pain management was measured using the global perioperative experience graded on a numeric scale of 0 - 10, with 0 indicating poor management to 10 indicating excellent pain management. Satisfaction is reported at 12-, 24-, 48-hours, and overall at home.</description>
          <population>Not all subjects returned their 48-hour diary.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Child's Satisfaction - at 12-hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="17"/>
                    <count group_id="O2" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.8" lower_limit="0" upper_limit="10"/>
                    <measurement group_id="O2" value="6.6" lower_limit="0" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Child's Satisfaction - at 24-hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="17"/>
                    <count group_id="O2" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.6" lower_limit="0" upper_limit="10"/>
                    <measurement group_id="O2" value="5.6" lower_limit="0" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Child's Satisfaction - at 48-hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.5" lower_limit="0" upper_limit="10"/>
                    <measurement group_id="O2" value="7.1" lower_limit="0" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Child's Satisfaction - Total time at home</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.1" lower_limit="0" upper_limit="10"/>
                    <measurement group_id="O2" value="5.9" lower_limit="0" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Parent's Satisfaction - at 12-hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="17"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.8" lower_limit="0" upper_limit="10"/>
                    <measurement group_id="O2" value="7.1" lower_limit="0" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Parent's Satisfaction - at 24-hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.4" lower_limit="0" upper_limit="10"/>
                    <measurement group_id="O2" value="6.5" lower_limit="0" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Parent's Satisfaction - at 48-hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="17"/>
                    <count group_id="O2" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.1" lower_limit="0" upper_limit="10"/>
                    <measurement group_id="O2" value="7.6" lower_limit="0" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Parent's Satisfaction - Total time at home</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="17"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.9" lower_limit="0" upper_limit="10"/>
                    <measurement group_id="O2" value="6.5" lower_limit="0" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Mean Pain Score in the Postoperative Period</title>
        <description>The Verbal Numeric Scale (VNS) asks patients to verbally state a number between 0 and 10 that corresponds to their present pain intensity. 0 = no pain and 10 = worst possible pain ever. Pain was measured by the child subject in the PACU at arrival, 15-, 30-, 60- and 120-minutes. Pain was assessed by the child subject and a parent at home at 12-, 24-, and 48-hours after surgery. The results represent a mean of all verbal pain scores in the PACU, while at home, and overall.</description>
        <time_frame>From admission to PACU to 48 hours after surgery</time_frame>
        <population>Some subjects in the PACU did not have VNS collected. In addition, not all of the 48-hour diaries were returned to allow for at home calculations.</population>
        <group_list>
          <group group_id="O1">
            <title>Ultrasound Guided Supraclavicular Block</title>
            <description>Patients randomized to the supraclavicular block group will receive an ultrasound guided nerve block with 0.2 ml/kg ropivacaine 0.5% (maximum 10 ml), using the technique described by Marhofer et al. In order to decrease variance in success rates, the ultrasound guided nerve block will be performed by 1 of the 4 anesthesiology co-investigators, each of whom have successfully performed over 100 ultrasound guided blocks in the past. Supraclavicular blocks were performed using the higher frequency of the probe and placing it in a coronal-oblique-plane in the supraclavicular fossa.&#xD;
Ropivacaine: Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction. Patients randomized to the supraclavicular block group will receive an ultrasound guided nerve block with 0.2 ml/kg ropivacaine 0.5% (maximum 10 ml).</description>
          </group>
          <group group_id="O2">
            <title>IV Opioids</title>
            <description>Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction.&#xD;
Fentanyl: Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction.</description>
          </group>
        </group_list>
        <measure>
          <title>The Mean Pain Score in the Postoperative Period</title>
          <description>The Verbal Numeric Scale (VNS) asks patients to verbally state a number between 0 and 10 that corresponds to their present pain intensity. 0 = no pain and 10 = worst possible pain ever. Pain was measured by the child subject in the PACU at arrival, 15-, 30-, 60- and 120-minutes. Pain was assessed by the child subject and a parent at home at 12-, 24-, and 48-hours after surgery. The results represent a mean of all verbal pain scores in the PACU, while at home, and overall.</description>
          <population>Some subjects in the PACU did not have VNS collected. In addition, not all of the 48-hour diaries were returned to allow for at home calculations.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>PACU</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="30"/>
                    <count group_id="O2" value="33"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.28" spread="1.88"/>
                    <measurement group_id="O2" value="4.76" spread="2.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Home</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="17"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.85" spread="2.55"/>
                    <measurement group_id="O2" value="3.49" spread="2.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PACU + Home</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="31"/>
                    <count group_id="O2" value="34"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.46" spread="2.44"/>
                    <measurement group_id="O2" value="4.44" spread="2.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>up to 48 hours after surgery</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Ultrasound Guided Supraclavicular Block</title>
          <description>Patients randomized to the supraclavicular block group will receive an ultrasound guided nerve block with 0.2 ml/kg ropivacaine 0.5% (maximum 10 ml), using the technique described by Marhofer et al. In order to decrease variance in success rates, the ultrasound guided nerve block will be performed by 1 of the 4 anesthesiology co-investigators, each of whom have successfully performed over 100 ultrasound guided blocks in the past. Supraclavicular blocks were performed using the higher frequency of the probe and placing it in a coronal-oblique-plane in the supraclavicular fossa.&#xD;
Ropivacaine: Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction. Patients randomized to the supraclavicular block group will receive an ultrasound guided nerve block with 0.2 ml/kg ropivacaine 0.5% (maximum 10 ml).</description>
        </group>
        <group group_id="E2">
          <title>IV Opioids</title>
          <description>Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction.&#xD;
Fentanyl: Patients randomized to the systemic analgesia group will receive 1mcg/kg of fentanyl IV after induction.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="38"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Chris D. Glover, MD, MBA, Principal Investigator</name_or_title>
      <organization>Baylor College of Medicine</organization>
      <phone>832-824-5800</phone>
      <email>cdglover@texaschildrens.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

